A recent survey of 1726 individuals revealed their perceptions about drug safety.
The poll, which was conducted by Harris Interactive and the Pharmaceutical Safety Institute, found that:
• 52% of respondents felt it is very or highly important to receive safety information on drugs
• 33% of respondents often or always seek drug safety data for themselves, a family member, or someone they provide with care
• 53% of respondents felt that a physician or health care provider is a source they trust to receive more information about the side effects of drugs
• 69% of respondents are confident that the drug companies release information they have about a drug?s adverse reactions as soon as it becomes available
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs